Bushra S. Alasmri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bushra S. Alasmri has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Aesha Farheen Siddiqui
Department of Family and Community Medicine, College of Medicine, King Khalid University, Abha 62529, Saudi Arabia
1 shared publication - Amar Abdullah A. Alqahtani
College of Medicine, King Khalid University, Abha 61421, Saudi Arabia
1 shared publication - Ashwaq M. Assiri
Department of Obstetrics and Gynecology, Abha Maternity and Children Hospital, Abha, Saudi Arabia
1 shared publication - Ayman Hussien Shaamash
Department of Obstetrics and Gynecology, College of Medicine, King Khalid University, Abha, Saudi Arabia
1 shared publication - Jaber Ibrahim Assiri
Department of Obstetrics and Gynecology, The Medical City of King Khalid University, Abha, Saudi Arabia
1 shared publication - Mamdoh Eskandar
Department of Obstetrics and Gynecology, College of Medicine, King Khalid University, Abha, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 10 September 2026
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 31 (1) , 72
Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
Background: Dopamine agonists are increasingly used to prevent ovarian hyperstimulation syndrome (OHSS), but the evidence remains fragmented. We synthesized comparative evidence on cabergoline for preventing moderate-to-severe OHSS in women undergoing IVF/ICSI, analysing randomized and non-randomized evidence as separate evidence streams. Methods: PubMed/MEDLINE, Embase, and the Cochrane Library were searched from inception to 1 May 2026. Randomized controlled trials (RCTs) and prospective non-randomized comparative studies comparing cabergoline with placebo or no treatment were eligible. Two reviewers independently performed selection, data extraction, and risk-of-bias assessment (RoB 2, ROBINS-I). In accordance with Cochrane guidance, randomized and non-randomized studies were not combined: the pooled estimate from the RCTs constituted the primary analysis, and the non-randomized studies were pooled separately as supportive evidence. Moderate-to-severe OHSS was expressed as an odds ratio (OR) using a random-effects model; certainty was rated with GRADE for each evidence stream. Results: Eight studies (969 women) were included: six RCTs (748 women) and two prospective non-randomized comparative studies (221 women). In the primary analysis restricted to the six RCTs, cabergoline was associated with a lower incidence of moderate-to-severe OHSS (OR 0.41, 95% CI 0.26–0.64; I² = 18%; 138 events). The two non-randomized studies, analysed separately, gave a consistent estimate (OR 0.21, 95% CI 0.07–0.66; I² = 0%). Assuming a baseline risk of 100 per 1,000 women, this corresponds to 57 fewer cases of moderate-to-severe OHSS per 1,000 women (95% CI 34 to 72 fewer). The estimate was robust in leave-one-out analysis (range OR 0.33–0.47) and after excluding the trial subject to an Expression of Concern (OR 0.42, 95% CI 0.25–0.73). No funnel-plot asymmetry was detected (Egger’s P = 0.90), but with six trials publication bias could not be reliably excluded. Clinical pregnancy, live birth, and adverse events were inconsistently reported and were not pooled. Certainty of evidence was Low for the randomized stream and Very low for the non-randomized stream. Conclusions: Low-certainty evidence indicates that cabergoline may reduce the incidence of moderate-to-severe OHSS in women undergoing IVF/ICSI. The available data did not identify a clear adverse signal for clinical pregnancy, live birth, or maternal adverse events, but were insufficient to determine these effects reliably. Cabergoline should be positioned as an adjunctive measure alongside, not instead of, contemporary primary prevention strategies.
- 10 September 2026
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 31 (1) , 72
Open AccessCabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
Background: Dopamine agonists are increasingly used to prevent ovarian hyperstimulation syndrome (OHSS), but the evidence remains fragmented. We synthesized comparative evidence on cabergoline for preventing moderate-to-severe OHSS in women undergoing IVF/ICSI, analysing randomized and non-randomized evidence as separate evidence streams. Methods: PubMed/MEDLINE, Embase, and the Cochrane Library were searched from inception to 1 May 2026. Randomized controlled trials (RCTs) and prospective non-randomized comparative studies comparing cabergoline with placebo or no treatment were eligible. Two reviewers independently performed selection, data extraction, and risk-of-bias assessment (RoB 2, ROBINS-I). In accordance with Cochrane guidance, randomized and non-randomized studies were not combined: the pooled estimate from the RCTs constituted the primary analysis, and the non-randomized studies were pooled separately as supportive evidence. Moderate-to-severe OHSS was expressed as an odds ratio (OR) using a random-effects model; certainty was rated with GRADE for each evidence stream. Results: Eight studies (969 women) were included: six RCTs (748 women) and two prospective non-randomized comparative studies (221 women). In the primary analysis restricted to the six RCTs, cabergoline was associated with a lower incidence of moderate-to-severe OHSS (OR 0.41, 95% CI 0.26–0.64; I² = 18%; 138 events). The two non-randomized studies, analysed separately, gave a consistent estimate (OR 0.21, 95% CI 0.07–0.66; I² = 0%). Assuming a baseline risk of 100 per 1,000 women, this corresponds to 57 fewer cases of moderate-to-severe OHSS per 1,000 women (95% CI 34 to 72 fewer). The estimate was robust in leave-one-out analysis (range OR 0.33–0.47) and after excluding the trial subject to an Expression of Concern (OR 0.42, 95% CI 0.25–0.73). No funnel-plot asymmetry was detected (Egger’s P = 0.90), but with six trials publication bias could not be reliably excluded. Clinical pregnancy, live birth, and adverse events were inconsistently reported and were not pooled. Certainty of evidence was Low for the randomized stream and Very low for the non-randomized stream. Conclusions: Low-certainty evidence indicates that cabergoline may reduce the incidence of moderate-to-severe OHSS in women undergoing IVF/ICSI. The available data did not identify a clear adverse signal for clinical pregnancy, live birth, or maternal adverse events, but were insufficient to determine these effects reliably. Cabergoline should be positioned as an adjunctive measure alongside, not instead of, contemporary primary prevention strategies.
- Top Cited PapersOpen Access
- 14 July 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (14) , 2029
The Prevalence and Associated Factors of Academic Stress among Medical Students of King Khalid University: An Analytical Cross-Sectional Study
Medical students are the category of academic population with the highest levels of stress. This study aimed to assess the prevalence of academic stress among medical students in Saudi Arabia and to identify its associated factors. This cross-sectional study was conducted at the College of Medicine at King Khalid University, Abha. The Medical Student Stressor Questionnaire (MSSQ) was used to evaluate the stress caused by different factors. A total of 422 medical students participated in this study. Among the participants, 115 (27.3%) were male and 307 (72.7%) were female. The highest percentage of students were perceiving moderate to severe stress due to academic-related stressors (97.1%), followed by teaching- and learning-related stressors (93.9%) and group activities-related stressors (88.3%). The lowest domain in which students perceived moderate to severe stress was drive and desire-related stressors (65.8%). The mean percentage of students who perceived moderate-to-severe stress in all domains of stressors was 85.5%. We can conclude that medical students have a high degree of stress, and we emphasize the importance of implementing stress management programs to teach students how to handle stress in order to avoid negative effects on their health and academic performance.
- 14 July 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (14) , 2029
Top Cited PapersOpen AccessThe Prevalence and Associated Factors of Academic Stress among Medical Students of King Khalid University: An Analytical Cross-Sectional Study
Medical students are the category of academic population with the highest levels of stress. This study aimed to assess the prevalence of academic stress among medical students in Saudi Arabia and to identify its associated factors. This cross-sectional study was conducted at the College of Medicine at King Khalid University, Abha. The Medical Student Stressor Questionnaire (MSSQ) was used to evaluate the stress caused by different factors. A total of 422 medical students participated in this study. Among the participants, 115 (27.3%) were male and 307 (72.7%) were female. The highest percentage of students were perceiving moderate to severe stress due to academic-related stressors (97.1%), followed by teaching- and learning-related stressors (93.9%) and group activities-related stressors (88.3%). The lowest domain in which students perceived moderate to severe stress was drive and desire-related stressors (65.8%). The mean percentage of students who perceived moderate-to-severe stress in all domains of stressors was 85.5%. We can conclude that medical students have a high degree of stress, and we emphasize the importance of implementing stress management programs to teach students how to handle stress in order to avoid negative effects on their health and academic performance.